Patrick Vermersch

Neurology — Centre Hospitalier Universitaire de Lille, France

LeadR Profile

2 974 ScienceLeadR Reputation 2974
Network Map

Neurology

Subspecialties: Immunology - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1990 - 2026

Source: PubMed

Centre Hospitalier Universitaire de Lille

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 810

Citations

Citations: 36 877 1st author: 100 Last author: 176 Unique author: 25


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
French expert opinion on the long-term management of relapsing multiple sclerosis with cladribine tablets beyond year 4.
sclerosis, multiple sclerosis, tablets, neurosurgery, cladribine, therapeutics, neurology
J Neurol20260
Long-term efficacy of cladribine tablets: Results from the MAGNIFY-MS Extension study.
multiple sclerosis, safety, tablets, cladribine, therapeutics, wounds and injuries, cognition
Mult Scler20261
Modulation of the immunological and neuroinflammatory microenvironment in older people with multiple sclerosis.
sclerosis, multiple sclerosis, aging, brain, immunosenescence, immune system diseases, therapeutics
Front Immunol20260
Efficacy and Safety of Patients With Relapsing Multiple Sclerosis Switching to Ocrelizumab Due to Suboptimal Treatment Response: Results of the 4-Year CASTING-LIBERTO Trial.
treatment outcome, sclerosis, multiple sclerosis, safety, magnetic resonance imaging, therapeutics, nervous system diseases
Eur J Neurol20260
Validation and psychometric properties of the Multiple Sclerosis Autonomy Score (MSAS) in a French cohort: The FOCAL-MS 2 study.
sclerosis, multiple sclerosis, psychometrics
Mult Scler Relat Disord20260

Clinical Studies 45

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 6

By phase:

Phase 3 33
N/A 7
Phase 4 3
Phase 2 2

By status:

Completed 30
Active not recruiting 5
Terminated 3
Not yet recruiting 2
Recruiting 2
Unknown 2
Suspended 1

By type:

Interventional 40
Observational 5

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 0
multicentric5to9 2
multicentricup10 38

Main Topics

Cohort/Consortium Investigators 15

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A study to investigate long term safety and tolerability of tolebrutinib in participants with multiple sclerosis
2023-503631-18-01 — sclerosis, multiple sclerosis, safety, nervous system, nervous system diseases, primary progressive multiple sclerosis, secondary progressive multiple sclerosis
Phase 3Active not recruiting2024
Efficacy and safety of remibrutinib compared to teriflunomide in participants with relapsing multiple sclerosis followed by long term treatment with remibrutinib
2023-509372-41-00 — sclerosis, multiple sclerosis, safety, therapeutics
Phase 3Active not recruiting2022
A Study Evaluating the Patient Perspective of the Physical Impact of Multiple Sclerosis and Providing Continued Access to Treatment in Patients with Multiple Sclerosis Previously Enrolled in a Genentech and or F Hoffmann La Roche Ltd Sponsored Study and without Access to A Post Trial Access Program
2023-507633-21-01 — sclerosis, multiple sclerosis, therapeutics
Phase 3Not yet recruiting2024
LONG TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMAB IN FRENCH PATIENTS WITH PROGRESSIVE MS CONSONANCE EXTENSION STUDY
2024-516433-13-00 — safety
Phase 3Recruiting2024
A Rollover Study to Evaluate the Long Term Safety and Efficacy of Ocrelizumab In Patients with Multiple Sclerosis
2023-505974-14-00 — sclerosis, multiple sclerosis, safety
Phase 3Active not recruiting2022

LeadR Networks

Main global connection map